Iovance Biotherapeutics, Inc. (IOVA) Analysis

One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a neighboring country.

That's how you're supposed to lose it all, right?

Alright, I just spent some time on the WSB sub, the last hour (or maybe two, who's counting?) diving deep into the IOVA DD that's been making waves, and wow, my FOMO is hitting critical levels. I feel like I just woke up from a coma and missed the biggest party of the year. Seriously, I've completely missed out again.

As we all know over the past few weeks we have seen multiple tickers like $IOVA with high short interests explode, even $INMB shot up 30% yesterday without WSB, as people are looking for the next short squeeze purely off of share float and short interest. This is where my prediction of $MLGO comes in, a company down over 98% from march when it's last short squeeze happened sitting at 155m mcap with a 55% short interest with low float as well. I truly think there's a good chance it get's squeeze ...